Big pharma firms have paused nearly £2bn in UK investments this year

Governments plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fearsBig pharmaceutical companies have ditched or paused nearly £2bn in planned UK investments so far this year, causing suffering to patients, as ministers gear up for discussions with Donald Trump amid a row over drug pricing.The governments plan for the life science sector, a key pillar of the economy, has been thrown into disarray, after US drugmaker MSDs shock announcement last Wednesday tha...